Levin Capital Strategies’s Accendra Health ACH Stock Holding History

Levin Capital Strategies’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$32K	–	218
2019 Q2	$32K	Hold	10,000	–	–	﹤0.01%	207
2019 Q1	$41K	Buy	+10,000	New	+$63.2K	﹤0.01%	190

Other funds holding ACH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Levin Capital Strategies's ACH Position: Q3 2019 in Review

Levin Capital Strategies sold out of Accendra Health (ACH) in Q3 2019, closing a stake of 10,000 shares — an estimated $32K sold.

Levin Capital Strategies first reported a position in ACH in Q1 2019 and held it in 2 quarters. The position peaked at $41K in Q1 2019. 175 funds tracked by Wall St. Rank hold ACH as of Q3 2019.

Levin Capital Strategies reported no remaining Accendra Health position as of Q3 2019 after selling out during the quarter.
Levin Capital Strategies sold 10,000 Accendra Health shares in Q3 2019, an estimated $32K.
Levin Capital Strategies first reported a position in Accendra Health in Q1 2019 and held it in 2 quarters.
Levin Capital Strategies's Accendra Health position peaked at $41K in Q1 2019.
175 funds tracked by Wall St. Rank held Accendra Health as of Q3 2019.

Based on Levin Capital Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.